Shareholders Of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 To Discuss Your Rights ANRO
Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
CLASS PERIOD: This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering conducted on or about February 2, 2024; and/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive.
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) The Company's product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe; (ii) accordingly, ALTO-100's clinical, regulatory, and commercial prospects were overstated; (iii) as a result, Alto's business and/or financial prospects were overstated; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
DEADLINE: September 19, 2025 Shareholders should not delay in registering for this class action. Register your information here:
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of ANRO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 19, 2025. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: ...
Phone: (646) 453-8903


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Japan Well Intervention Market Size To Reach USD 776.0 Million By 2033 CAGR Of 4.50%
- Vietnam Artificial Intelligence Market Size, Share, Growth, Demand And Report 2025-2033
- Industrial Hose Market Size, Trends, Growth Factors, Latest Insights And Forecast 2025-2033
- Nutritional Bar Market Size To Expand At A CAGR Of 3.5% During 2025-2033
- What Does The Europe Cryptocurrency Market Report Reveal For 2025?
- North America Perms And Relaxants Market Size, Share And Growth Report 2025-2033
Comments
No comment